[{"id":"382c9498-ae64-48ce-a05f-dcf78ea1d165","acronym":"","url":"https://clinicaltrials.gov/study/NCT03997968","created_at":"2021-08-12T18:53:32.634Z","updated_at":"2024-07-02T16:35:42.822Z","phase":"Phase 1/2","brief_title":"A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors","source_id_and_acronym":"NCT03997968","lead_sponsor":"Cyteir Therapeutics, Inc.","biomarkers":" ER • PGR • MYC • BCL2","pipe":" | ","alterations":" HER-2 positive • HER-2 negative • ER negative • ER positive + PGR positive • PGR positive • MYC translocation • PGR negative","tags":["ER • PGR • MYC • BCL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • HER-2 negative • ER negative • ER positive + PGR positive • PGR positive • MYC translocation • PGR negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e gemcitabine • Rituxan (rituximab) • capecitabine • bendamustine • CYT-0851"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 170","initiation":"Initiation: 10/09/2019","start_date":" 10/09/2019","primary_txt":" Primary completion: 07/30/2024","primary_completion_date":" 07/30/2024","study_txt":" Completion: 12/30/2024","study_completion_date":" 12/30/2024","last_update_posted":"2023-07-17"},{"id":"23643ccd-1224-410a-86ab-8453a562d715","acronym":"CRUKD/12/004","url":"https://clinicaltrials.gov/study/NCT01791595","created_at":"2021-01-18T07:56:09.533Z","updated_at":"2025-02-25T15:05:29.958Z","phase":"Phase 1","brief_title":"A Phase I Trial of AZD3965 in Patients With Advanced Cancer","source_id_and_acronym":"NCT01791595 - CRUKD/12/004","lead_sponsor":"Cancer Research UK","biomarkers":" SLC16A1","pipe":"","alterations":" ","tags":["SLC16A1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AZD-3965"],"overall_status":"Completed","enrollment":" Enrollment 53","initiation":"Initiation: 04/23/2013","start_date":" 04/23/2013","primary_txt":" Primary completion: 11/17/2020","primary_completion_date":" 11/17/2020","study_txt":" Completion: 11/17/2020","study_completion_date":" 11/17/2020","last_update_posted":"2022-04-11"}]